Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Guizhou Redstar Development is a leading Chinese chemical enterprise specializing in the research, production, and sale of barium, strontium, and manganese salts. The company is a critical global supplier of pharmaceutical-grade barium sulfate, an essential contrast medium used in medical diagnostic imaging such as X-rays and CT scans. Beyond its healthcare applications, Redstar produces high-purity chemicals for the electronics and energy sectors, including materials for lithium-ion batteries. Headquartered in Anshun, Guizhou, the company is publicly traded on the Shanghai Stock Exchange and maintains a dominant position in the global barium salt market.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Guizhou Redstar Development.